Annual Current Liabilities
$27.88 M
+$12.92 M+86.38%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual total current liabilities is $27.88 million, with the most recent change of +$12.92 million (+86.38%) on December 31, 2021.
- During the last 3 years, PHAS annual current liabilities has risen by +$23.31 million (+509.20%).
Performance
PHAS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$24.68 M
+$2.99 M+13.79%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly total current liabilities is $24.68 million, with the most recent change of +$2.99 million (+13.79%) on June 30, 2022.
- Over the past year, PHAS quarterly current liabilities has increased by +$8.51 million (+52.58%).
Performance
PHAS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PHAS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +86.4% | +52.6% |
| 3 y3 years | +509.2% | +329.5% |
| 5 y5 years | +58.5% | - |
PHAS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -11.5% | -12.1% |
| 5 y | 5-year | at high | -69.6% | -11.5% | -69.6% |
| alltime | all time | at high | -97.0% | -11.5% | -84.6% |
PhaseBio Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $24.68 M(+13.8%) |
| Mar 2022 | - | $21.69 M(-22.2%) |
| Dec 2021 | $27.88 M(+86.4%) | $27.88 M(+29.9%) |
| Sep 2021 | - | $21.46 M(+32.7%) |
| Jun 2021 | - | $16.17 M(-3.0%) |
| Mar 2021 | - | $16.67 M(+11.4%) |
| Dec 2020 | $14.96 M | $14.96 M(+31.6%) |
| Sep 2020 | - | $11.37 M(-36.1%) |
| Jun 2020 | - | $17.80 M(+137.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $7.50 M(-11.6%) |
| Dec 2019 | $8.48 M(+85.3%) | $8.48 M(+42.2%) |
| Sep 2019 | - | $5.96 M(+3.8%) |
| Jun 2019 | - | $5.75 M(+51.3%) |
| Mar 2019 | - | $3.80 M(-17.0%) |
| Dec 2018 | $4.58 M(-74.0%) | $4.58 M(-40.5%) |
| Sep 2018 | - | $7.69 M(+50.2%) |
| Jun 2018 | - | $5.12 M(-70.9%) |
| Dec 2017 | $17.59 M(+1984.7%) | $17.59 M |
| Dec 2016 | $844.00 K | - |
FAQ
- What is PhaseBio Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual current liabilities year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly current liabilities year-on-year change?
What is PhaseBio Pharmaceuticals annual total current liabilities?
The current annual current liabilities of PHAS is $27.88 M
What is the all time high annual current liabilities for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual total current liabilities is $27.88 M
What is PhaseBio Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, PHAS annual total current liabilities has changed by +$12.92 M (+86.38%)
What is PhaseBio Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of PHAS is $24.68 M
What is the all time high quarterly current liabilities for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly total current liabilities is $27.88 M
What is PhaseBio Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, PHAS quarterly total current liabilities has changed by +$8.51 M (+52.58%)